 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | 4SCAR-PSMA T cells / SZGIMI
New P1/2 trial, CAR T-Cell Therapy: PSMA-specific CAR-T Cell Therapy (clinicaltrials.gov) - Jun 11, 2020
P1/2, N=100, Recruiting, Sponsor: Shenzhen Geno-Immune Medical Institute